Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 3, 2009, Pages 427-432

  Lee, Hyo Jin ^a   Cho, Do Yeun ^b   Park, Ji Chan ^c   Bae, Sang Byung ^d   Lee, Kyu Taek ^d   Cho, In Sung ^e   Han, Chang Soon ^f   Park, Suk Young ^c   Yun, Hwan Jung ^a   Kim, Samyong ^a  

^a Chungnam National University College of Medicine   (South Korea)

^b Konyang University College of Medicine   (South Korea)

^c Daejeon St Mary's Hospital   (South Korea)

^d Soonchunhyang University College of Medicine   (South Korea)

^e Eulji University   (South Korea)

^f Cheongju St Mary's Hospital   (South Korea)

Author keywords

5 Fluorouracil; Biweekly; Gastric cancer; Leucovorin; Paclitaxel

Indexed keywords

FLUOROURACIL; FOLINIC ACID; PACLITAXEL; PAXEL; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; INFECTION; INOPERABLE CANCER; LEUKOPENIA; MALE; METASTASIS; MORBIDITY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROPATHY; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; STOMACH CANCER; STOMATITIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; DISEASE COURSE; DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; STOMACH TUMOR; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; PACLITAXEL; RECURRENCE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 58249137855     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0752-4     Document Type: Article

References (38)

1. DM Roder 2002 The epidemiology of gastric cancer Gastric Cancer 5 Suppl 1 5 11 (Pubitemid 36604663)
2. JM Bae YJ Won KW Jung JG Park 2002 Annual report of the Korea Central Cancer Registry Program 2000: based on registered data from 131 hospitals Cancer Res Treat 34 77 83
3. P Pisani DM Parkin F Bray J Ferlay 1999 Estimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 83 18 29 (Pubitemid 29409471)
4. A Verdecchia A Mariotto G Gatta MT Bustamante-Teixeira W Ajiki 2003 Comparison of stomach cancer incidence and survival in four continents Eur J Cancer 39 1603 1609 (Pubitemid 36829201)
5. SS Wöhrer M Raderer M Hejna 2004 Palliative chemotherapy for advanced gastric cancer Ann Oncol 15 1585 1595 (Pubitemid 39567288)
6. P Schöffski 2002 New drugs for treatment of gastric cancer Ann Oncol 13 Suppl 4 13 22 (Pubitemid 35363748)
7. J Wils 1998 Treatment of gastric cancer Curr Opin Oncol 10 357 361 (Pubitemid 28375320)
8. U Vanhoefer H Wilke HJ Weh M Clemens A Harstrick M Stahl DK Hossfeld S Seeber 1994 Weekly high-dose 5-fluorouracil and folinic acid as salvage treatment in advanced gastric cancer Ann Oncol 5 850 851 (Pubitemid 24341880)
9. E Jäger H Bernhard O Klein B Wächter F Theiss W Dippold KH Meyer zum Büschenfelde A Knuth 1995 Combination 5-fluorouracil (FU), folinic acid (FA), and alpha-interferon 2B in advanced gastric cancer: results of a phase II trial Ann Oncol 6 153 156
10. CH Hsu KH Yeh LT Chen JM Liu CM Jan JT Lin YC Chen AL Cheng 1997 Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers: an effective and low-toxic regimen for patients with poor general condition Oncology 54 275 280 (Pubitemid 27252721)
11. J Parness SB Horwitz 1981 Taxol binds to polymerized tubulin in vitro J Cell Biol 91 479 487 (Pubitemid 12215635)
12. YF Chang LL Li CW Wu TY Liu WY Lui FK P'eng CW Chi 1996 Paclitaxel-induced apoptosis in human gastric carcinoma cell lines Cancer 77 14 18 (Pubitemid 26002731)
13. A Ohtsu N Boku F Tamura K Muro Y Shimada K Saigenji S Akazawa M Kitajima R Kanamaru T Taguchi 1998 An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer Am J Clin Oncol 21 416 419 (Pubitemid 28366916)
14. Y Yamada K Shirao A Ohtsu N Boku I Hyodo H Saitoh Y Miyata T Taguchi 2001 Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions Ann Oncol 12 1133 1137 (Pubitemid 32834495)
15. S Cascinu R Ficarelli MA Safi F Graziano G Catalano R Cellerino 1997 A phase I study of paclitaxel and 5-fluorouracil in advanced gastric cancer Eur J Cancer 33 1699 1702 (Pubitemid 28123496)
16. JL Grem D Nguyen BP Monahan V Kao FJ Geoffroy 1999 Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells Biochem Pharmacol 58 477 486 (Pubitemid 29281549)
17. NK Kim YS Park DS Heo C Suh SY Kim KC Park YK Kang DB Shin HT Kim HJ Kim WK Kang CI Suh YJ Bang 1993 A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer Cancer 71 3813 3818 (Pubitemid 23172955)
18. M Ychou C Astre P Rouanet JM Fabre B Saint-Aubert J Domergue D Ribard AJ Ciurana C Janbon H Pujol 1996 A phase II study of 5-fluorouracil, leucovorin and cisplatin (FLP) for metastatic gastric cancer Eur J Cancer 32A 1933 1937 (Pubitemid 26361687)
19. JS [tmp] MacDonald PS Schein PV Woolley T Smythe W Ueno D Hoth F Smith M Boiron C Gisselbrecht R Brunet C Lagarde 1980 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer Ann Intern Med 93 533 536 (Pubitemid 10015173)
20. JA Wils HO Klein DJ Wagener H Bleiberg H Reis F Korsten T Conroy M Fickers S Leyvraz M Buyse 1991 Sequential high-dose methotrexate and fluorouracil combined with doxorubicin-a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group J Clin Oncol 9 827 831
21. A Zaniboni S Barni R Labianca G Marini G Pancera G Giaccon E Piazza A Signaroldi W Legnani G Luporini 1995 Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report Cancer 76 1694 1699
22. H Wilke P Preusser U Fink W Achterrath L Lenaz M Stahl C Schober H Link HJ Meyer B Lucke 1990 High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer-a phase II study in elderly patients or patients with cardiac risk Invest New Drugs 8 65 70 (Pubitemid 20087246)
23. P Preusser H Wilke W Achterrath U Fink L Lenaz A Heinicke J Meyer HJ Meyer H Buente 1989 Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer J Clin Oncol 7 1310 1317 (Pubitemid 19220134)
24. Y Chao KH Yeh CJ Chang LT Chen TY Chao MF Wu CS Chang JY Chang CY Chung WY Kao RK Hsieh AL Cheng 2004 Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer Br J Cancer 91 453 458 (Pubitemid 39106839)
25. C Louvet T Andre JM Tigaud E Gamelin JY Douillard R Brunet E Francois JH Jacob D Levoir A Taamma P Rougier E Cvitkovic A de Gramont 2002 Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients J Clin Oncol 20 4543 4548 (Pubitemid 35407422)
26. JA Ajani J Fairweather P Dumas YZ Patt R Pazdur PF Mansfield 1998 Phase II study of Taxol in patients with advanced gastric carcinoma Cancer J Sci Am 4 269 274 (Pubitemid 28354929)
27. JG Kim SK Sohn HS Song KY Kwon YR Do KH Lee MS Hyun HM Ryoo SH Bae KU Park JH Baek WS Lee JS Chung GJ Cho CH Sohn JS Jang HY Chung W Yu 2007 Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer Cancer Chemother Pharmacol 60 863 869 (Pubitemid 47389392)
28. C Bokemeyer CS Lampe MR Clemens JT Hartmann D Quietzsch L Forkmann C Kollmannsberger L Kanz 1997 A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer Anticancer Drugs 8 396 399 (Pubitemid 27204960)
29. C Kollmannsberger D Quietzsch C Haag T Lingenfelser M Schroeder JT Hartmann W Baronius V Hempel M Clemens L Kanz C Bokemeyer 2000 A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer Br J Cancer 83 458 462 (Pubitemid 30487857)
30. SM Gadgeel AF Shields LK Heilbrun S Labadidi M Zalupski R Chaplen PA Philip 2003 Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancer Am J Clin Oncol 26 37 41 (Pubitemid 36210894)
31. AM Murad A Petroianu RC Guimaraes BC Aragao LO Cabral AO Scalabrini-Neto 1999 Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel, safe, and effective regimen Am J Clin Oncol 22 580 586 (Pubitemid 30266056)
32. F Honecker C Kollmannsberger D Quietzsch C Haag M Schroeder C Spott JT Hartmann W Baronius V Hempel L Kanz C Bokemeyer 2002 Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer Anticancer Drugs 13 497 503 (Pubitemid 34624633)
33. YH Kim SW Shin BS Kim JH Kim JG Kim YJ Mok CS Kim HS Rhyu JH Hyun JS Kim 1999 Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma Cancer 85 295 301 (Pubitemid 29051282)
34. Y Chao CP Li TY Chao WC Su RK Hsieh MF Wu KH Yeh WY Kao LT Chen AL Cheng 2006 An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer Br J Cancer 95 159 163 (Pubitemid 44055884)
35. NN Zhou ZM Zhou MZ Liu YH Li RH Xu XY Teng XJ Xiang WH Tian DG Liu PL Hu B Zhang HJ Qiu SY Qian YJ He 2003 Preliminary report of semimonthly 5-fluorouracil/leucovorin combined with paclitaxel in treatment of advanced gastric cancer (AGC) Ai Zheng 22 867 869
36. JF Feng JW Lu XF Sun 2004 Biweekly regimen of high dose of leucovorin, 5-fluorouracil, and paclitaxel for patients with advanced gastric cancer Ai Zheng 23 1704 1706
37. AD Wagner W Grothe J Haerting G Kleber A Grothey WE Fleig 2006 Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data J Clin Oncol 24 2903 2909 (Pubitemid 46630593)
38. C Pinto F Di Fabio S Siena S Cascinu FL Rojas Llimpe C Ceccarelli V Mutri L Giannetta S Giaquinta C Funaioli R Berardi C Longobardi E Piana AA Martoni 2007 Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study) Ann Oncol 18 510 517 (Pubitemid 46359631)